Albuvirtide in Combination With 3BNC117 in Virologically Suppressed Subjects With HIV-1 Infection

NCT04819347 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV/AIDS

Interventions

DRUG: Albuvirtide
DRUG: 3BNC117

Sponsor

Frontier Biotechnologies Inc.